{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:14:38Z","timestamp":1785831278382,"version":"3.56.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.jaad.2009.03.049","type":"journal-article","created":{"date-parts":[[2009,7,4]],"date-time":"2009-07-04T04:30:07Z","timestamp":1246681807000},"page":"421-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Long-term safety of repeated administrations of a new formulation of botulinum toxin type A in the treatment of glabellar lines: Interim analysis from an open-label extension study"],"prefix":"10.1016","volume":"61","author":[{"given":"Gary D.","family":"Monheit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel L.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2009.03.049_bib1","series-title":"FDA approves Dysport for therapeutic and aesthetic uses [press release]","year":"2009"},{"key":"10.1016\/j.jaad.2009.03.049_bib2","first-page":"67","article-title":"Botulinum toxin in the treatment of frontoglabellar and periorbital wrinkles: an initial study","volume":"40","author":"Ascher","year":"1995","journal-title":"Ann Chir Plast Esthet"},{"key":"10.1016\/j.jaad.2009.03.049_bib3","first-page":"25","article-title":"Facial rejuvenation by non-endoscopic lifting and botulinum toxin injection","volume":"45","author":"Ascher","year":"2000","journal-title":"Cahiers Ophthalmol"},{"key":"10.1016\/j.jaad.2009.03.049_bib4","first-page":"528","article-title":"Botulinum toxin A treatment of overactive corrugator supercilii in thyroid eye disease","volume":"82","author":"Olver","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2009.03.049_bib5","first-page":"14","article-title":"Combination treatment of glabellar rhytids","volume":"7","author":"Erian","year":"1999","journal-title":"Int J Cosmet Surg"},{"key":"10.1016\/j.jaad.2009.03.049_bib6","first-page":"65","article-title":"Treatment of dynamic facial wrinkles with botulinum toxin type A (Dysport)\u2013a pilot study","volume":"26","author":"Feller","year":"2000","journal-title":"Akt Dermatol"},{"key":"10.1016\/j.jaad.2009.03.049_bib7","first-page":"526","article-title":"Botulinum toxin and facial wrinkles: a new injection procedure","volume":"5","author":"Le Louarn","year":"1998","journal-title":"Ann Chir Plast Esthet"},{"key":"10.1016\/j.jaad.2009.03.049_bib8","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1524-4725.1998.tb04100.x","article-title":"Botulinum toxin type A for facial rejuvenation: United States and United Kingdom perspectives","volume":"24","author":"Lowe","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2009.03.049_bib9","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1111\/j.1524-4725.2006.32332.x","article-title":"A randomized, double-blind, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of optimal dose","volume":"33","author":"Monheit","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2009.03.049_bib10","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jaad.2006.07.006","article-title":"Comparison of two formulations of botulinum toxin type A for the treatment of glabellar lines: a double-blind, randomized study","volume":"55","author":"Lowe","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.03.049_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaad.2003.11.084","article-title":"A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines","volume":"51","author":"Asher","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.03.049_bib12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1365-2133.2003.05436.x","article-title":"Gladys Study Group. Reproducibility of a four-point clinical severity score for glabellar frown lines","volume":"149","author":"Honeck","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.03.049_bib13","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1111\/j.1524-4725.2006.32327.x","article-title":"German-Austrian Retrospective Study Group. Repeated botulinum toxin A injections for the treatment of lines in the upper face: a retrospective study of 4,103 treatments in 945 subjects","volume":"33","author":"Rzany","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2009.03.049_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.asj.2005.05.004","article-title":"Botulinum toxin A in the treatment of glabellar lines: scheduling the next injection","volume":"25","author":"Ascher","year":"2005","journal-title":"Aesthetic Surg J"},{"key":"10.1016\/j.jaad.2009.03.049_bib15","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1067\/mjd.2002.121356","article-title":"A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines","volume":"46","author":"Carruthers","year":"2002","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209005118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209005118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:14:31Z","timestamp":1759270471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962209005118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0190962209005118"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2009.03.049","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term safety of repeated administrations of a new formulation of botulinum toxin type A in the treatment of glabellar lines: Interim analysis from an open-label extension study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2009.03.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}